Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD

Overview of attention for article published in Gastroenterology, January 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source

twitter: 17 X users

Readers on

mendeley: 122 Mendeley

So far, Altmetric has seen 22 X posts from 17 X users, with an upper bound of 66,166 followers.

RT @EdwardLoftus2: Selecting End Points for Disease-Modification Trials in #IBD SPIRIT Consensus @IOIBD1 https://t.co/FveEGwtStV @AGA_Gast…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 18 additional X posts.